XTX Topco Ltd Has $10.99 Million Holdings in Johnson & Johnson (NYSE:JNJ)

Key Points

• XTX Topco Ltd increased its stake in Johnson & Johnson by 132.4% in the first quarter, holding 66,246 shares valued at approximately $10.99 million.
• Johnson & Johnson's most recent earnings report showed an EPS of $2.77, exceeding analysts' estimates, and a year-over-year revenue increase of 5.8% to $23.74 billion.
• The company announced a quarterly dividend of $1.30 per share, expected to yield a total of $5.20 annually with a payout ratio of 55.61%.

XTX Topco Ltd increased its stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 132.4% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 66,246 shares of the company's stock after acquiring an additional 37,736 shares during the period. Johnson & Johnson makes up approximately 0.6% of XTX Topco Ltd's holdings, making the stock its 6th largest holding. XTX Topco Ltd's holdings in Johnson & Johnson were worth $10,986,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of JNJ. Lantz Financial LLC boosted its position in Johnson & Johnson by 3.3% during the 1st quarter. Lantz Financial LLC now owns 11,974 shares of the company's stock valued at $1,986,000 after purchasing an additional 377 shares during the period. Sulzberger Capital Advisors Inc. acquired a new position in Johnson & Johnson during the 4th quarter valued at approximately $453,000. Joel Isaacson & Co. LLC boosted its position in Johnson & Johnson by 3.5% during the 1st quarter. Joel Isaacson & Co. LLC now owns 74,132 shares of the company's stock valued at $12,294,000 after purchasing an additional 2,526 shares during the period. State of Wyoming boosted its position in Johnson & Johnson by 205,580.0% during the 4th quarter. State of Wyoming now owns 10,284 shares of the company's stock worth $1,487,000 after acquiring an additional 10,279 shares during the period. Finally, Range Financial Group LLC boosted its position in Johnson & Johnson by 18.9% during the 1st quarter. Range Financial Group LLC now owns 15,886 shares of the company's stock worth $2,635,000 after acquiring an additional 2,529 shares during the period. 69.55% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Wall Street Zen lowered Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a research report on Friday, July 18th. Bank of America upped their price objective on Johnson & Johnson from $161.00 to $175.00 and gave the company a "neutral" rating in a report on Thursday, July 17th. Leerink Partners lowered Johnson & Johnson from an "outperform" rating to a "market perform" rating and cut their price objective for the company from $169.00 to $153.00 in a report on Tuesday, May 13th. Sanford C. Bernstein restated a "market perform" rating on shares of Johnson & Johnson in a report on Wednesday, April 16th. Finally, Leerink Partnrs lowered Johnson & Johnson from a "strong-buy" rating to a "hold" rating in a report on Tuesday, May 13th. Nine equities research analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $174.50.

Johnson & Johnson Stock Down 0.5%

NYSE:JNJ traded down $0.80 during trading hours on Wednesday, hitting $167.31. 6,177,929 shares of the company's stock traded hands, compared to its average volume of 7,975,042. The firm has a market cap of $402.94 billion, a P/E ratio of 17.89, a P/E/G ratio of 2.14 and a beta of 0.41. Johnson & Johnson has a twelve month low of $140.68 and a twelve month high of $169.99. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.76 and a current ratio of 1.01. The stock's fifty day moving average price is $156.93 and its two-hundred day moving average price is $156.30.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last issued its earnings results on Wednesday, July 16th. The company reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.09. Johnson & Johnson had a return on equity of 32.49% and a net margin of 25.00%. The company had revenue of $23.74 billion for the quarter, compared to analyst estimates of $22.85 billion. During the same period in the prior year, the firm posted $2.82 EPS. The business's revenue was up 5.8% compared to the same quarter last year. On average, research analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 26th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, August 26th. This represents a $5.20 annualized dividend and a dividend yield of 3.11%. Johnson & Johnson's dividend payout ratio (DPR) is presently 55.61%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.